Development and multicenter validation of an AI-driven detection system for DLBCL cells in bone marrow smears

The presence of diffuse large B-cell lymphoma (DLBCL) cells in bone marrow (BM) smears is recognised as a key morphological basis for diagnosing BM involvement by DLBCL. BM involvement directly affects disease staging, treatment strategies, and prognosis assessment. Nevertheless, traditional manual identification of DLBCL cells in BM smears under a microscope is time-consuming, subject to observer variability, and lacks standardization between hospitals. In this study, we developed an artificial intelligence (AI) detection system (DLBCL-CQnet) based on deep learning, using BM smears from 117 patients with newly diagnosed DLBCL across four centers. DLBCL-CQnet comprises a region of interest (ROI) classification model based on MobileNetV2, and a cell detection and classification model (CDC-MOD) based on YOLOv8. Performance was evaluated using accuracy, precision, recall, F1-score, and mean average precision at an intersection over union threshold of 0.5 (mAP50). MobileNetV2 achieved the best ROI classification performance (accuracy 0.925, precision 0.922, F1-score 0.919), while YOLOv8 yielded a classification accuracy of 0.890 and an mAP50 of 0.934 for DLBCL cell detection. The system achieved an ROI classification accuracy of 0.925, a cell classification accuracy of 0.890, and a mean average precision (mAP50) of 0.934 at an intersection-over-union (IoU) threshold of 0.5. The optimal cutoff for identifying BM infiltration by DLBCL cells was 2.12%, with a specificity of 0.941 and positive predictive value (PPV) of 0.923, demonstrating high diagnostic value. The recognition speed significantly outperforms manual assessment, substantially reducing time consumption. DLBCL-CQnet enables automated, standardized identification of DLBCL cells in BM smears across institutions, serving as a reliable auxiliary diagnostic tool for assessing BM involvement by DLBCL. Its high specificity and operational efficiency streamline diagnostic workflows, especially in resource-constrained environments.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-07-17
DOI
https://doi.org/10.1038/s41598-026-59908-7
Primary Topic
Digital Imaging for Blood Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and multicenter validation of an AI-driven detection system for DLBCL cells in bone marrow smears

Can Lin, Xiaojun Xia, Xing Wu, Y Li et al.
Scientific Reports
Digital Imaging for Blood Diseases
article

Development and multicenter validation of an AI-driven detection system for DLBCL cells in bone marrow smears

Can Lin, Xiaojun Xia, Xing Wu, Y Li, Mingyu Zhao, Shuyue Chen, Longrong Ran, Lian Li, Yao Liu, Yakun Zhang, Li Li, Xuelian Wu, Yang Zailin, Yu Peng, Yuanyou Yao, Wei Zhang, Jun Li, Shuang Chen, Zheng Li
article en

Abstract

The presence of diffuse large B-cell lymphoma (DLBCL) cells in bone marrow (BM) smears is recognised as a key morphological basis for diagnosing BM involvement by DLBCL. BM involvement directly affects disease staging, treatment strategies, and prognosis assessment. Nevertheless, traditional manual identification of DLBCL cells in BM smears under a microscope is time-consuming, subject to observer variability, and lacks standardization between hospitals. In this study, we developed an artificial intelligence (AI) detection system (DLBCL-CQnet) based on deep learning, using BM smears from 117 patients with newly diagnosed DLBCL across four centers. DLBCL-CQnet comprises a region of interest (ROI) classification model based on MobileNetV2, and a cell detection and classification model (CDC-MOD) based on YOLOv8. Performance was evaluated using accuracy, precision, recall, F1-score, and mean average precision at an intersection over union threshold of 0.5 (mAP50). MobileNetV2 achieved the best ROI classification performance (accuracy 0.925, precision 0.922, F1-score 0.919), while YOLOv8 yielded a classification accuracy of 0.890 and an mAP50 of 0.934 for DLBCL cell detection. The system achieved an ROI classification accuracy of 0.925, a cell classification accuracy of 0.890, and a mean average precision (mAP50) of 0.934 at an intersection-over-union (IoU) threshold of 0.5. The optimal cutoff for identifying BM infiltration by DLBCL cells was 2.12%, with a specificity of 0.941 and positive predictive value (PPV) of 0.923, demonstrating high diagnostic value. The recognition speed significantly outperforms manual assessment, substantially reducing time consumption. DLBCL-CQnet enables automated, standardized identification of DLBCL cells in BM smears across institutions, serving as a reliable auxiliary diagnostic tool for assessing BM involvement by DLBCL. Its high specificity and operational efficiency streamline diagnostic workflows, especially in resource-constrained environments.

Scientific Reports
Army Medical University (CN), Chongqing University (CN), Daping Hospital (CN), Southwest Hospital (CN), Chongqing Emergency Medical Center (CN), Chongqing Cancer Hospital (CN)
Wenzhou Medical University, Fudan University, Sichuan University, Fundamental Research Funds for the Central Universities, West China Hospital, Sichuan University
Decent work and economic growth
Openalex Percentile: Top 8%
Digital Imaging for Blood Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.